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Abstract  
Cyclosporine A (CsA) and tacrolimus (FK506), a member of calcineurin inhibitors, 
inhibit inflammation process as part of immune response. Nuclear activated T cells subfamily 
NFAT1 is a trascription factor responsible for the regulation of immune response genes. 
Streptococcus intermedius, an oral commensal bacterium, has been shown to strongly associate 
with liver abscess.  The S. intermedius strains produce intermedilysin (ILY), which is responsible 
for the bacterial virulence. Cyclosporine A and FK506 have been widely used to control NFAT 
activation in most of cell types, however the ability of CsA and FK506 to inhibit ILY-induced 
NFAT1 activation remains to be investigated. The aim of this study was to investigate the effect 
of  CsA and FK506 on NFAT1 activation caused by ILY. Human cholangiocellular cell line 
HuCCT1 was stimulated with various concentrations of ILY. The cell and nuclear 
morphological change was observed by microscopy analysis. The NFAT1 nuclear translocation 
that indicates its activation was detected by immunocytochemistry. The inhibitory effect of CsA 
and FK506 was tested after 30 min application before ILY treatment by using 
immunofluorescence microscope. The results showed cell and nuclear shrinkage in ILY-treated 
cells. The NFAT1 was translocated to the nuclei in HuCCT1 cells, and observed in dose 
dependent manner.  Cyclosporine A and FK506 inhibited ILY-induced NFAT1 nuclear 
translocation.  In conclusion, CsA and FK506 may act as potent inflammation control agents in 
S. intermedius ILY-infected cells. 
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INTRODUCTION  
 
The transcription nuclear factor of activated T 
cell (NFAT) which is responsible for immune and 
inflammatory responses contains five members, 
NFAT1, NFAT2, NFAT3, NFAT4, and NFAT5.  
Among them, NFAT1, NFAT2, NFAT3, and 
NFAT4 are regulated by calcium-calcineurin 
signalling pathway (Macian, 2005).  The signalling 
pathway regulated by NFAT covers a board number 
of functions in vertebrate development such as 
immune system, nervous system, heart and sceletal 
muscle, vascular system, lung, bone and skeleton, 
endocrine system, and skin epithelia (Wu et al., 
2007). 
Nuclear factor of activated T cell is 
responsible for the cellular responses against 
bacterial toxin.  A virulence factor produced by 
Helicobacter pylori, CagA, activates NFAT2 in 
human gastric epithelial cells under regulation of 
PLCγ-Ca
2+
-calcineurin pathway (Yokoyama et al., 
2005).  
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That study demonstrates that NFAT2 is a common 
cellular target of H. pylori virulence factors, that 
might play important role in the pathogenesis of 
infection by this bacterium (Yokoyama et al., 2005). 
Streptococcus intermedius is a normal 
microflora that is clinically distributed in the oral 
cavity, gastrointestinal and genitourinary tracts 
(Whiley et al., 1990; Whiley et al., 1992).  This 
species has related to some deep site infections in 
brain, liver, and central nervous system (Whiley et 
al., 1990; Whiley et al., 1992; Yamamoto et al., 
1999; Wagner et al., 2006).  Some strains of S. 
intermedius produces intermedilysin (ILY) which 
acts as critical virulence factor of the infection by 
this bacterium.  Intermedilysin was firts identified 
and then purified from S. intermedius isolated from 
liver abscess (Nagamune et al., 1996; Nagamune et 
al., 2000).  Intermedilysin is known to be potential to 
induce increasing intracellular calcium [(Ca
2+
)i] in 
polymorphonuclear cells (Macey et al., 2001). 
Nuclear factor of activated T cell is very 
sensitive to the rise in (Ca
2+
)i (Dolmetsch et al.,  
1998).  Prior to its activation, NFAT should be 
dephosphorylated by a Ca
2+
-dependent enzyme, 
calcineurin, which facilitates its nuclear translocation 
(Luo et al., 1996, Jain et al., 1993).  Because of the 
critical role of NFAT activation in generating 
inflammatory and immune responses, it needs a 
control mechanism; however, it remains to be 
investigated.  This study subjected to find out the 
way to control NFAT activation in human 
cholangiocellular carcinoma cells HuCCT1 by using 
calcineurin inhibitors cyclosporine A (CsA) and 
tacrolimus (FK506).  
 
METHODS 
 
Cell culture  
Human cholangiocellular carcinoma cell line 
HuCCT1 was purcased from Japanese Health 
Science Research Resources Bank (Osaka, Japan).  
The cells were cultured in RPMI 1640 (Sigma-
Aldrich, St Louis, MO, USA) suplemented with 10% 
fetal bovine serum, 100 IU/ml penicillin, and 100 
g/ml streptomycin at 37°C in the presence of 5% 
CO2. 
 
Analysis of cell and nuclear morphology 
HuCCT1 cells were grown on 15 mm 
diameter cover slips and were cultured for overnight.  
Intermedilysin (40 ng/ml) was added to the cells 
followed by 24 h incubation.  In order to observe the 
cell and nuclear morphological change caused by 
ILY we analized ILY-treated cells using 
phasecontrast and fluorescence microscope (BX-50, 
Olympus Optical Co. Ltd, Tokyo, Japan).  
 
Immunocytochemistry 
In separated experiment, the cells were 
exposed to various dose of ILY (0 ng/ml, 5 ng/ml, 20 
ng/ml, 40 ng/ml)  within five min.  To invesitigate 
whether calcineurin inhibitor is able to blok ILY-
induced NFAT1 nuclear translocation, CsA (Tocris 
Cookson, Ellisville, MO, USA) and FK506 (Cayman 
Chemical, Ann Arbor, MI, USA) were applied for 30 
min before ILY treatment.  Following stimulation, 
the cells were fixed in 10% formalin prior to 
permeabilization using methanol.  After blocking 
with 4% BSA, the cells were exposed to mouse anti-
NFAT1 antibody (BD Transduction Laboratories, 
Lexington, KY, USA) for 45 min at room 
temperature.  Alexa Fluor 488 anti-mouse antibody 
(Invitrogen, Carlsbad, CA, USA) as secondary 
antibody was applied for 40 min and followed by 
nuclear staining with 10 µg/ml of Hoechst 33342.  
After serial PBS washing, the cells were then 
examined under a fluorescence microscope.  
 
RESULTS 
 
Cell and nuclear morphological change  
Under light microscope observation, untreated 
cells showed normal cell morphology (Fig. 1A) with 
an intact and normal size nuclei (Fig. 1B). Cell 
morphological change was observed in cells treated 
with 40 ng/ml ILY (Fig. 1C).  These cells showed 
small rounded apearance with lost of cytoplasmic 
processus. In addition, these treated cells also 
demonstrated condensed nuclei under Hoechst 
33342 nuclear staining (Fig. 1D).  
 
Nuclear translocation of NFAT1 in ILY-
treated HuCCT1 cells 
To determine that ILY could induce activation 
of NFAT and to investigate its cellular localization 
in HuCCT1 cell, we performed 
immunocytochemistry.  The results of 
immunocytochemical analysis in Figure 2A 
demonstrated that ILY treatment induced nuclear 
translocation of  NFAT1 indicating its activation 
under ILY stimulation.  In the Figure 2B, the results 
showed increase percentage of NFAT1 positive-
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translocation cells in HuCCT1 treated with various 
dose of ILY. 
This observation demonstrated ILY-induced NFAT1 
activation in dose dependent manner. 
 
Inhibitory effect of CsA and FK506 on 
NFAT1 nuclear translocation   
To study the molecular signalling of NFAT1 
activation induced by ILY, we did calcineurin 
inhibitor pretreatment on ILY-exposed HuCCT1 
cells.  The results demonstrated that calcineurin 
inhibitors CsA as well as FK506 completely bloked 
activation of NFAT1 (Fig. 3).  The inhibitory effect 
of CsA and FK506 was detected at the concentration 
of 100 nM and 5 ng/ml, respectively. 
 
 
Figure 1.  Cell morphological change caused by ILY-treatment was observed after 24 h ILY (40 ng/ml) 
treatment to HuCCT1 cells. The untreated cells showed intack cell morphology (A) with smooth 
nuclear membrane (B).  The ILY-treated cells showed smaller cell size with membrane blebbing (C).  
The nucleic acid staining using Hoechst 33342 revealed smooth rounded nuclei in normal cells (C) 
and pyknotic nuclei in treated cells (D).  Bar indicates 10 µm.  
A 
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Figure 2.  ILY induced nuclear translocation of NFAT1 in HuCCT1 cells. As shown as green fluorescence, the 
NFAT1 was located in the cytoplasma of untreated cells (A), and translocated to the nuclei of cells 
treated with 10 ng/ml ILY (B).  The percentage of NFAT1-positive translocation cells was increased 
in line with the increasing ILY concentration. Presented data was the mean ± SD of representative 
experiments. 
 
DISCUSSION  
 
This study notes that ILY induced cell death 
in HuCCT1 cells as demonstrated by destructive 
change of cell morphology and irreversible pyknosis 
nuclear.  This effect was detected in the utilization of 
nanomolar concentration of ILY, indicating that ILY 
is strong cytolytic toxin which has capability to 
induce cell death in HuCCT1 cells. Our result is in 
line with the previous study reporting the cytotoxic 
effect of ILY from bacterial culture supernatant on 
hepatoma HepG2 cells (Sukeno et al., 2005). In 
clinical sites, the infection caused by bacteria usually 
raised from a small amount of toxin. Low 
concentration of toxin in fact is capable to induce 
Ca
2+
 oscillations (Soderblom et al., 2002).  This 
phenomenon was observed in cells treated with 
sublytic dose of –hemolysin, cytolysin produced 
by Escherichia coli (Söderblom et al., 2002; Ludwig 
and Goebel, 2000). These evidences led us to study 
the early response of cells stimulated with low 
concentration of ILY, as the initial step to clarify the 
molecular backgorund of infection caused by S. 
intermedius. 
Upon stimulation, NFAT dephosphorylation 
occurs in short time before its translocation to the 
cell nucleus to facilitate its binding to a specific 
binding site in DNA (Shaw et al., 1995). In this 
study we demonstrated that ILY may induced 
NFAT1 dephosphorylation followed by nuclear 
translocation in HuCCT1 cells. This evidence was 
occure in five min after ILY exposure. This results is 
supported by previous studies that NFAT 
dephosphorylation is observed within 5-10 min after 
stimulation of calcium ionophore (Shaw et al., 1995; 
Wesselborg et al., 1996; Ruff and Leach, 1995). 
A 
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Figure 3.  ILY-induced NFAT1 activation was prevented by calcineurin inhibitor. Pretreatment of 100 nM CsA 
and 5 ng/ml FK506 completely inhibited the nuclear translocation of NFAT1 in HuCCT1 cells. Data 
represent the mean ± SD of representative experiments.  
 
 
NFAT is a molecular target of calcineurin 
inhibitors (Luo et al., 1996). Pretreatment of CsA 
and FK506 prevents the activation of calcineurin, 
subsequently bloks NFAT dephosphorylation and 
nuclear translocation (Ruff and Leach, 1995; 
McCaffrey et al., 1993). We demonstrate that CsA 
and FK506 completely blocked activation of 
NFAT1. Our study revealed that FK506 was more 
effective than CsA in preventing ILY-induced 
NFAT1 translocation. We estimate that the 
inhibition effect of FK506 was 16-fold more potent 
than CsA.  It might be explained by the evidence that 
FK506 also affects the CsA-insensitive activation 
pathway (Almawi and Melemedjian, 2000). The 
inhibitory effect of FK506 on NFAT activation 
pathway is initiated by its binding to FK506 binding 
protein FKBP. This inhibitor binds to FKBP to form 
FK506-FKBP stable complex (Liu et al., 1991; 
Addy et al., 2007).  
Concidering the ability of CsA and FK506 to 
prevent NFAT1 activation in ILY-treated HuCCT1 
cells, we suggest that these calcineurin inhibitors 
could function as a potent regulator of inflammatory 
response in the infection caused by ILY-producer S. 
intermedius. This study may be provide molecular 
background for the management of inflammation in 
human biliary disease that is generated by S. 
intermedius infection. 
   
CONCLUSION  
 
In conclusion, CsA and FK506 may act as 
potent inflammation control agents in S. intermedius 
ILY-infected cells. 
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